Home›Earnings›Previews›Astera Labs shares pull back after Q2 beat as stock st…

Astera Labs shares pull back after Q2 beat as stock stays below $360

The Q2 release showed revenue acceleration of 104.5%, and the stock’s $360 pivot is framed as the neckline for a potential head-and-shoulders reversal targeting around $480.

Reported · Written up by our desk · Previews

Astera Labs, listed on the Nasdaq under ALAB, posted a Q2 earnings release with accelerating performance, beating expectations and supporting a guidance increase, but shares still fell afterward in what MarketBeat characterizes as a sell-the-news reaction.

MarketBeat Ratings said the results reflected outperformance and margin strength, noting that analysts and market participants had already largely anticipated the upside even as trends and whisper figures pointed toward the high end of expectations.

The coverage highlights that Astera Labs’ reported 104.5% revenue growth in the quarter was a key part of the narrative, alongside momentum tied to its Scorpio product ramp that management said was advancing a quarter early.

MarketBeat also framed $360 as the critical pivot level, describing it as the neckline for a potential head-and-shoulders reversal with a projected trading range of about $120, which would imply a move back near record highs around $480 if the pattern confirms.

Latest closeNasdaq Comp. 26,348.35 ▼0.1%

More like this

Sources